Journal profile · Biochemistry, Genetics and Molecular Biology-Molecular Medicine
Advances in Biological Regulation
ISSN 2212-4926 · eISSN 2212-4934 · Elsevier
Advances in Biological Regulation: CAS Zone 3 · Biology (2026 Xinrui edition); impact factor 2.7 (journal website); hybrid open access; APC about USD 3,530; median 15 days to acceptance (48 articles, last 24 months); 41 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
Advances in Biological Regulation is published by Elsevier and is classed under Biology in the CAS Journal Ranking. By OpenAlex counts of its recent articles, its largest topics are Protein Kinase Regulation and GTPase Signaling, Cellular transport and secretion and PI3K/AKT/mTOR signaling in cancer, together about 28.4% of its articles. Its main subfields are Molecular Biology. (generated from OpenAlex topic counts and CAS ranking data)
Advances in Biological Regulation (formerly Advances in Enzyme Regulation) reports cutting edge scientific progress on regulation at the molecular level, covering:The molecular biology of control of gene expression by hormones, drugs and growth factors in cancer cells and in clinical situations of metabolic diseases, inborn errors of metabolism and neoplasia.Stem cell biology and regenerative medicine issuesRegulatory networks, mainly in cellular signalling, differentiation, cell cycle & growth control, structure-function relationships, cell fate and lineage commitment or assembly mechanisms in cellsViruses, or supramolecular constructs, and signaling mechanisms mediating transcriptionGenomic, proteomic, bioinformatics and systems biology approaches to identify and characterize steps of biological control in cells.Complex cellular, pathogenic, clinical, or animal model systems studied by biochemical, molecular, genetic, epigenetic or quantitative ultrastructural approaches
From the journal's Aims & Scope
Research area (LetPub): Biochemistry, Genetics and Molecular Biology-Molecular Medicine
Editor-in-chief Lucio CoccoPublisher website
Editorial board by country: none in mainland China; most named United States 17, Italy 6, United Kingdom 5, France 2, Switzerland 2 (36 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Protein Kinase Regulation and GTPase SignalingBiochemistry, Genetics and Molecular Biology10.9%
- Cellular transport and secretionBiochemistry, Genetics and Molecular Biology9.6%
- PI3K/AKT/mTOR signaling in cancerBiochemistry, Genetics and Molecular Biology8%
- Human auditory perception and evaluationEngineering6.7%
- Diverse Scientific and Economic StudiesEconomics, Econometrics and Finance6.5%
- Sphingolipid Metabolism and SignalingBiochemistry, Genetics and Molecular Biology5.8%
- Educational Robotics and EngineeringComputer Science5.5%
- Endoplasmic Reticulum Stress and DiseaseBiochemistry, Genetics and Molecular Biology4.5%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Biology Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Biology | Zone 3 |
| Minor | Biochemistry & Molecular Biology | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher)
- 2.7Publisher website ·
- CiteScore 2026-06
- 5.3LetPub ·
- CiteScore (publisher)
- 5.3Publisher website ·
- SJR 2026-06
- 0.89LetPub ·
- SNIP 2026-06
- 0.66LetPub ·
- h-index
- 70OpenAlex ·
- i10-index
- 369OpenAlex ·
- 2-year mean citedness
- 2.2OpenAlex ·
- Self-citation rate
- 3.7%LetPub ·
- Share of gold OA articles
- 36.59%LetPub ·
Volume
- Articles per year
- 24LetPub ·
Articles by year OpenAlex count · 650 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 21 | 6 | 4 |
| 2025 | 41 | 19 | 59 |
| 2024 | 37 | 25 | 155 |
| 2023 | 34 | 20 | 175 |
| 2022 | 45 | 27 | 401 |
| 2021 | 49 | 25 | 563 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
15 daysMedian, submission to acceptance · P25–P75 9 days – 34 days
- Acceptance to online
- median 3 days (48 articles)
- Submission to online
- median 23 days
- Sample
- 48 articles with submission and acceptance dates (61 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Submission to first decision
- 4 daysPublisher website ·
- First decision after review
- 17 daysPublisher website ·
- Submission to acceptance
- 11 daysPublisher website ·
- Acceptance to publication
- 2 daysPublisher website ·
- Peer review
- Single anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 3,530 / EUR 3,300 / GBP 2,830 / JPY 437,830 | — | — | |
| Publisher website | USD 3,750 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare4 items from the author guidelines
- Abstract
- ≤ 250 words
- Keywords
- 1–7
- Reference style
- Author–date
- Highlights
- Optional
Article types accepted4
- original research articleReview articles and original research articles.Length not stated
- original research articlesReview articles and original research articles.Length not stated
- review articleReview articles and original research articles.Length not stated
- review articlesReview articles and original research articles.Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Publication ethics, License & copyright, Open access, Peer review, Preprints
- AI use Declaration of generative AI use
Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…
Source ↗Publisher website ·- Authorship Group authorship
file format Model summary
Group authorship refers to the attribution of an article to a defined and named group of authors whose members have contributed to the work. Examples include research consortia, clinical trial groups, collaborative networks, task forces or working groups, expert panels or consensus groups, and participatory research groups. Group authorship must be declared on the title page at submission. When av…
Source ↗Publisher website ·- Conflicts of interest Declaration of competing interests
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence or bias their work. Examples of potential competing interests include:EmploymentConsultanciesStock ownershipHonorariaPaid expert testimonyPatent applications or registrationsGrants or any other fundingAffiliation with the journal as an Editor or Advisory Board …
Source ↗Publisher website ·- Publication ethics
ethics in publishing Model summary
Authors must follow ethical guidelines stated in Elsevier's Publishing Ethics Policy.
Source ↗Publisher website ·- License & copyright License options
Authors will be offered open access user license options which will determine how you, and third parties, can reuse your open access article. We advise that you review these options and any funding body license requirements before selecting a license option.
Source ↗Publisher website ·- Open access Open access
We refer you to our open access information page to learn about open access options for this journal.
Source ↗Publisher website ·- Peer review Peer review
single anonymized review process Model summary
This journal follows a single anonymized review process. Your submission will initially be assessed by our editors. If your submission is deemed suitable, it will typically be sent to be reviewed by a minimum of two reviewers for an independent expert assessment of the scientific quality. The decision as to whether your article is accepted or rejected for publication will be made by our editors.Re…
Source ↗Publisher website ·- Preprints Preprints
preprint sharing Model summary
Preprint sharingAuthors may share preprints in line with Elsevier's article sharing policy. Sharing preprints, such as on a preprint server, will not count as prior publication.We advise you to read our policy on multiple, redundant or concurrent publication. In support of Open Science, this journal offers its authors a free preprint posting service on SSRN, Elsevier’s preprint and early research …
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Elsevier
- ISSN
- 2212-4926
- Electronic ISSN
- 2212-4934
- Official links
- Journal homepage ↗LetPub
- Submission system ↗Publisher website
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Advances in Biological Regulation
What CAS zone is Advances in Biological Regulation in?
In the 2026 Xinrui edition it is in Zone 3 of Biology. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Advances in Biological Regulation?
The journal's website gives an impact factor of 2.7; this is the journal's own figure, as LetPub lists none for it; CiteScore 5.3, h-index 70.
How long does peer review take at Advances in Biological Regulation?
Based on the dates recorded on 48 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 15 days (interquartile range 9–34 days). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Advances in Biological Regulation?
According to the journal's author guidelines: Abstract: ≤ 250 words; Keywords: 1–7; Reference style: Author–date; Highlights: Optional. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Advances in Biological Regulation based?
Of the 36 board members whose country the journal's board page names, none are in mainland China; the countries named most often are United States (17), Italy (6) and United Kingdom (5). Counted from the institutions listed on the board page; for reference only.
Which databases index Advances in Biological Regulation?
According to LetPub and DOAJ records, Advances in Biological Regulation is indexed in ESCI and Scopus.
Is Advances in Biological Regulation open access, and what is the APC?
Advances in Biological Regulation is a hybrid journal. For open-access publication: APC about USD 3,530.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .